The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation
Authors
Keywords
-
Journal
LANCET INFECTIOUS DISEASES
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-03-20
DOI
10.1016/s1473-3099(21)00079-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
- (2021) Nicholas G. Davies et al. SCIENCE
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts
- (2020) Joel Hellewell et al. Lancet Global Health
- Estimating number of cases and spread of coronavirus disease (COVID-19) using critical care admissions, United Kingdom, February to March 2020
- (2020) Mark Jit et al. Eurosurveillance
- Early impact of the coronavirus disease (COVID-19) pandemic and physical distancing measures on routine childhood vaccinations in England, January to April 2020
- (2020) Helen I McDonald et al. Eurosurveillance
- Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period
- (2020) Stephen M. Kissler et al. SCIENCE
- Beyond COVID‐19: How the ‘dismal science’ can prepare us for the future
- (2020) Susan Chilton et al. HEALTH ECONOMICS
- Persistent Symptoms in Patients After Acute COVID-19
- (2020) Angelo Carfì et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study
- (2020) Amit Sud et al. LANCET ONCOLOGY
- Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit–risk analysis of health benefits versus excess risk of SARS-CoV-2 infection
- (2020) Kaja Abbas et al. Lancet Global Health
- Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study
- (2020) Nicholas G Davies et al. Lancet Public Health
- SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates
- (2020) Gregory A Poland et al. LANCET
- COVID-19 vaccine trials should seek worthwhile efficacy
- (2020) Philip Krause et al. LANCET
- Immune life history, vaccination, and the dynamics of SARS-CoV-2 over the next 5 years
- (2020) Chadi M. Saad-Roy et al. SCIENCE
- A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity
- (2020) Angkana T. Huang et al. Nature Communications
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Estimating the opportunity costs of bed-days
- (2017) Frank G. Sandmann et al. HEALTH ECONOMICS
- Risk in Vaccine Research and Development Quantified
- (2013) Esther S. Pronker et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search